Outpatient metformin use is associated with reduced severity of COVID‐19 disease in adults with overweight or obesity

Observational studies suggest outpatient metformin use is associated with reduced mortality from coronavirus disease‐2019 (COVID‐19). Metformin is known to decrease interleukin‐6 and tumor‐necrosis factor‐α, which appear to contribute to morbidity in COVID‐19. We sought to understand whether outpati...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:J Med Virol
Κύριοι συγγραφείς: Bramante, Carolyn T., Buse, John, Tamaritz, Leonardo, Palacio, Ana, Cohen, Ken, Vojta, Deneen, Liebovitz, David, Mitchell, Nia, Nicklas, Jacinda, Lingvay, Ildiko, Clark, Jeanne M., Aronne, Louis J., Anderson, Erik, Usher, Michael, Demmer, Ryan, Melton, Genevieve B., Ingraham, Nicholas, Tignanelli, Christopher J.
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: John Wiley and Sons Inc. 2021
Θέματα:
Research Articles
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8013587/
https://ncbi.nlm.nih.gov/pubmed/33580540
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jmv.26873
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια